Fan Yang

Fan Yang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Medicine
Verified
Journal Article
Open access
LZLan-Zhi Zhang
Lan-Zhi Zhang
LHLi-Yan Huang
Li-Yan Huang
AHAn-Liang Huang
An-Liang Huang
JLJin-Xing Liu
Jin-Xing Liu
FYFan Yang
Fan Yang
Squamous carcinoma is the most common malignancy of vagina. Adenoid cystic carcinoma (ACC) in the vagina is very rare. In the present study, we present a 45-year-old woman with a palpable swelling in the vagina. The patient reported body paresthesia, chest congestion, expiratory dyspnea, and itching in the thigh root. The ultrasound results revealed inhomogeneous echoes of the muscular layer in the middle and distal of the vagina, and probed a slightly richer blood flow signal. Then biopsy was performed. On microscopic examination, it was observed that tumor cells were arranged in a tubular or cribriform pattern, and exhibited a consistent size, small nuclei, and nuclear fission. The myoepithelium was lined around the glandular cavity, but the myoepithelium was tumorous. Immunohistochemistry was performed for further verification. Vimentin was positive in mesenchyme and CK-P was positive in epithelial cells. P63 and calponin were spotted, which were focal positive around the glandular cavity. Finally, the patient was diagnosed as ACC. At last, the patient chose chemoradiotherapy, not surgical excision. The patient is alive and well 13 months after the initial diagnosis. ACC in the vagina is extremely rare. To our knowledge, this report is the first case of ACC arising from the vagina in English-language literature. Extensive surgical section of the tumour and chemoradiotherapy are recommended for therapy. Because of rarity, the prognosis of ACC in vagina is not known.

1 January 2021 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
SCSijing Chen
Sijing Chen
YWYawen Wang
Yawen Wang
FYFan Yang
Fan Yang
KWKana Wang
Kana Wang
YZYing Zheng
Ying Zheng
Ahead of Print article withdrawn by publisher.

6 December 2025 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
ZSZunlin Shi
Zunlin Shi
ZLZhi Li
Zhi Li
YLYirou Li
Yirou Li
FYFan Yang
Fan Yang
S: Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to alleviate pain associated with endometriosis (EMS), yet the impact of their long-term use on disease progression remains unclear. This study investigates the dual role of NSAIDs in EMS pathogenesis using network toxicology and Mendelian randomization (MR). Methods: The toxicity and ADMET profiles of nine NSAIDs were screened using ProTox 3.0 and ADMETlab 2.0. Potential drug targets were predicted using PharmMapper, STITCH, and SwissTargetPrediction, while EMS-related targets were retrieved from GeneCards, OMIM, and CTD databases. For the MR analysis, cis-eQTLs for whole blood tissue from GTEx v8 served as instrumental variables, based on the inflammatory nature of endometriosis. Outcome data were from an independent GWAS summary dataset (19,588 cases, 213,669 controls). Our analysis adhered to MR independence assumptions, ensuring no sample overlap between exposure and outcome data. Functional enrichment and molecular docking explored the underlying mechanisms. Results: By integrating drug targets with disease genes, we first identified 463 overlapping targets. We revealed that EPHB4 is a core hub mediating the potential “risk-promoting” effects of nearly all NSAIDs, with its functions enriched in key pathological processes such as angiogenesis. Molecular docking confirmed that eight NSAIDs could stably bind to EPHB4 . Crucially, we found that indomethacin exhibited a unique “dual-regulatory” pattern: it simultaneously targeted the protective target PTGER4 and the risk-associated target EPHB4 . Molecular docking further substantiated, at the atomic level, that indomethacin possesses strong binding affinity for both targets, providing a structural biology explanation for its observed genetic effects. Interpretation: This study provides, for the first time, robust causal evidence from both genetic and structural biology perspectives for the “double-edged sword” attribute of NSAIDs in EMS, and proposes a new paradigm of “target-oriented heterogeneous effects.” We found that specific NSAIDs might inadvertently promote disease progression by activating the EPHB4 pathway, while indomethacin stands out as a key exception due to its unique dual-action mechanism. These findings not only offer a critical explanation for the current clinical controversy but also lay a solid scientific foundation for advancing EMS management from “empirical medication” towards “precision-based selection guided by molecular mechanisms.” Graphical Highlight: Proposing a New Paradigm: By constructing a multi-dimensional analytical framework that integrates network toxicology, causal inference, and structural biology, this study is the first to reveal the“target-oriented heterogeneous effects” of NSAIDs in the treatment of dysmenorrhea caused by endometriosis, challenging the traditional “one-size-fits-all” treatment model. Identifying Key Targets: This study established a complete evidence chain from “target screening” to “causal inference” and finally to “structural validation,” identifying for the first time EPHB4 as the central hub gene mediating the potential risk effects of NSAIDs and elucidating that its function is primarily achieved through angiogenesis pathways. Elucidating a Complex Mechanism: Through cross-validation between genetic causality and molecular structural simulation, we elucidated the unique “dual regulation” mode of indomethacin: mediating a protective effect via PTGER4 while simultaneously mediating a potential risk via EPHB4. Providing Structural Evidence: Molecular docking simulations provided structural biology evidence at the atomic level for the aforementioned genetic effects, confirming that indomethacin possesses high-affinity binding potential with both PTGER4 and EPHB4. Guiding Precision Medication: This study provides a computationally driven, critical basis for the precision medication of endometriosis. It not only offers theoretical support for considering indomethacin as a preferred option but also points the way for the development of novel NSAIDs that avoid the EPHB4 pathway.

2 March 2026 in Environmental Health
Verified
Journal Article
Open access
ZSZunlin Shi
Zunlin Shi
ZLZhi Li
Zhi Li
YLYirou Li
Yirou Li
FYFan Yang
Fan Yang
The environmental flame retardant tris(1,3-dichloro-2-propyl) phosphate (TDCPP) is epidemiologically associated with several core risk factors for ovarian cancer (such as hormonal dysregulation and infertility); however, the molecular mechanisms linking these adverse health outcomes remain unclear. This knowledge gap limits the precision and specificity of risk assessment. This study aims to utilize bioinformatics methods to suggest potential molecular pathways through which TDCPP influences the development of ovarian cancer. We employed an integrative analysis strategy combining computational toxicology and multi-omics data. Molecular docking simulations were utilized to evaluate potential molecular binding. Statistical analyses involved differential expression analysis, miRNA target prediction, and pathway enrichment to identify key regulatory networks. Our analysis identified potential associations between TDCPP (and its metabolite BDCPP) and three key ovarian cancer genes related to prognosis: MMP3 (invasion), and CYP3A4 and CYP3A43 (chemotherapy resistance). Multi-omics analysis identified an miRNA signature (miR-3677/3135/4436 family) associated with gene co-regulation. Given the liver-enriched characteristics of these miRNAs, we proposed a novel “liver-to-ovary crosstalk” hypothesis model of distal tumor progression. In this model, TDCPP exposure may involve the release of exosomes carrying dysregulated miRNAs from hepatocytes, thereby potentially remotely regulating ovarian gene expression. Furthermore, molecular docking simulations suggested that TDCPP and BDCPP could theoretically interact with the protein domains of MMP3 and CYP3A4, providing atomic-level clues for potential molecular binding effects. Starting from epidemiological associations, this study provides bioinformatics evidence regarding potential molecular mechanisms linking TDCPP to ovarian cancer risk. The proposal of miRNA-related regulatory pathways and a “liver-to-ovary crosstalk” hypothesis model offers a new perspective for understanding the systemic toxicity of the environmental pollutant TDCPP. Importantly, these findings provide testable hypotheses for future experimental validation and offer molecular-level clues for interpreting difficult-to-explain clinical cases, highlighting their significant public health and scientific value. Not applicable. This study suggests that the environmental pollutant tris(1,3-dichloro-2-propyl) phosphate (TDCPP) may promote the progression of ovarian cancer via a novel "liver-to-ovary crosstalk." Employing a progressive three-stage strategy, we first identified core targets (e.g., MMP3, CYP3A4) by integrating multi-source data and computational toxicology. Subsequently, we deciphered a synergistic miRNA regulatory network, indicating potential mechanisms involving the reprogramming of genetic and epigenetic codes. Finally, we provided supportive clues for this cross-organ crosstalk and its potential impact across multiple scales, ranging from atomic docking and cellular experiments to clinical data. This work offers a new perspective for the risk assessment, mechanistic elucidation, and therapeutic intervention of ovarian cancer. The online version contains supplementary material available at 10.1186/s12940-026-01280-0. The online version contains supplementary material available at 10.1186/s12940-026-01280-0.

8 September 2026 in Gynecologic Oncology
Verified
Journal Article
Open access
LDLusi Deng
Lusi Deng
YZYing Zheng
Ying Zheng
FYFan Yang
Fan Yang
QWQiao Wang
Qiao Wang
YCYu Chen
Yu Chen
XYXu Yang
Xu Yang
To compare oncologic and perioperative outcomes between minimally invasive radical hysterectomy (MIS-RH) without a uterine manipulator and open radical hysterectomy (O-RH) for early-stage cervical cancer (CC). This retrospective propensity-score-matched cohort study included 1798 patients treated from 2019 to 2023 (539 MIS-RH and 1259 O-RH). All MIS-RH procedures were performed without a uterine manipulator and incorporated uterine-exposure techniques and protective vaginal transection. After 1:1 matching, 539 patients remained in each group. The primary outcome was disease-free survival (DFS); secondary outcomes included overall survival (OS), perioperative outcomes, and postoperative complications. Median potential follow-up was shorter after MIS-RH (18.93 vs 31.30 months). Recurrence occurred in 18 and 30 patients, respectively, and 17 deaths were recorded (9 vs 8). DFS did not differ significantly between MIS-RH and O-RH (HR, 0.863; 95% CI, 0.480-1.553; P = .623), nor did OS (HR, 1.735; 95% CI, 0.666-4.518; P = .259). Results remained consistent after calendar-year adjustment and administrative censoring at 24 months. MIS-RH was associated with lower estimated blood loss (100 vs 300 mL), fewer intraoperative transfusions (0.56% vs 6.31%), shorter time to first flatus (48 vs 60 h), and shorter postoperative hospitalization (6 vs 7 days), but longer operative time (260 vs 235 min; all P < .001). No statistically significant DFS or OS differences were detected between manipulator-free MIS-RH and O-RH. MIS-RH was associated with several favorable perioperative outcomes, but shorter follow-up and the small number of deaths preclude conclusions of equivalence or noninferiority. Longer follow-up and prospective validation are required.